Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients with a germline BRCA mutation and metastatic pancreatic vancer (mPC): Phase III POLO trial Meeting Abstract


Authors: Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A.; Tortora, G.; Algul, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. Y.; Schlienger, K.; Locker, G. Y.; Kindler, H. L.
Abstract Title: Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients with a germline BRCA mutation and metastatic pancreatic vancer (mPC): Phase III POLO trial
Meeting Title: 50th Anniversary Joint Meeting of American Pancreatic Association (APA) and Japan Pancreas Society (JPS)
Journal Title: Pancreas
Volume: 48
Issue: 10
Meeting Dates: 2019 Nov 6-9
Meeting Location: Maui, HI
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2019-11-01
Start Page: 1433
End Page: 1434
Language: English
ACCESSION: WOS:000505712800157
PROVIDER: wos
DOI: 10.1097/MPA.0000000000001419
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly